- ASP Isotopes (ASPI, Financial) completes agreements with TerraPower for HALEU production and supply.
- Successful operation of three new isotope production facilities in South Africa.
- ASPI announces potential Johannesburg Stock Exchange listing and Renergen Limited acquisition.
ASP Isotopes (ASPI), a leader in advanced materials and isotope production, has achieved a series of significant milestones includes entering definitive agreements with TerraPower. These agreements encompass loan financing for a new High Assay Low-Enriched Uranium (HALEU) production facility and supply contracts for up to 150 metric tons of HALEU over the next decade.
The company has operationalized three production facilities in South Africa employing its proprietary Aerodynamic Separation Process (ASP) and Quantum Enrichment technology. These facilities specialize in producing Carbon-14, Silicon-28, and Ytterbium-176. The Silicon-28 facility has commenced operations under two signed contracts, while the Ytterbium-176 facility is producing commercial samples with full-scale production slated for the second half of 2025.
Further expanding its footprint, ASPI has proposed a secondary listing on the Johannesburg Stock Exchange to increase liquidity and access capital. Additionally, the company is exploring a potential acquisition of Renergen Limited, aiming to create a global leader in critical materials.
